Advancing Familial Hypercholesterolemia Detection and Management in South Korea.
作者信息
Bae Jae Hyun
机构信息
Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
出版信息
Korean Circ J. 2024 Nov;54(11):739-742. doi: 10.4070/kcj.2024.0244. Epub 2024 Aug 12.
Abstract
摘要
相似文献
1
Advancing Familial Hypercholesterolemia Detection and Management in South Korea.推进韩国家族性高胆固醇血症的检测与管理
Korean Circ J. 2024 Nov;54(11):739-742. doi: 10.4070/kcj.2024.0244. Epub 2024 Aug 12.
2
Population specific genetic heterogeneity of familial hypercholesterolemia in South Africa.南非家族性高胆固醇血症的人群特异性遗传异质性。
Curr Opin Lipidol. 2018 Apr;29(2):72-79. doi: 10.1097/MOL.0000000000000488.
3
Dyslipidemia Fact Sheet in South Korea, 2022.2022 年韩国血脂异常情况简要说明
Diabetes Metab J. 2023 Sep;47(5):632-642. doi: 10.4093/dmj.2023.0135. Epub 2023 Aug 2.
5
Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods.家族性高胆固醇血症检测的进展、差距和机遇：当前和未来筛查及检测方法概述。
Curr Opin Lipidol. 2020 Dec;31(6):347-355. doi: 10.1097/MOL.0000000000000714.
6
Enhancing Familial Hypercholesterolemia Detection in South Korea: A Targeted Screening Approach Integrating National Program and Genetic Cascade Screening.加强韩国家族性高胆固醇血症的检测：一种整合国家项目和基因级联筛查的靶向筛查方法。
Korean Circ J. 2024 Nov;54(11):726-738. doi: 10.4070/kcj.2024.0107. Epub 2024 Jul 1.
7
Familial hypercholesterolemia in South Africa.南非的家族性高胆固醇血症
Semin Vasc Med. 2004 Feb;4(1):93-5. doi: 10.1055/s-2004-822991.
8
Dyslipidemia Fact Sheet in South Korea, 2022.2022年韩国血脂异常情况说明书
J Lipid Atheroscler. 2023 Sep;12(3):237-251. doi: 10.12997/jla.2023.12.3.237. Epub 2023 Jul 31.
9
Prevalence of cardiovascular risk factors in South Korean adults: results from the Korea Medical Insurance Corporation (KMIC) Study.韩国成年人心血管危险因素的患病率：韩国医疗保险公社（KMIC）研究结果
Ann Epidemiol. 1998 Jan;8(1):14-21. doi: 10.1016/s1047-2797(97)00131-2.
10
Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.南欧远交人群家族性高胆固醇血症的基因诊断：低密度脂蛋白（LDL）受体基因突变对辛伐他汀治疗总胆固醇、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇反应的影响
J Clin Endocrinol Metab. 2001 Oct;86(10):4926-32. doi: 10.1210/jcem.86.10.7899.
本文引用的文献
1
Enhancing Familial Hypercholesterolemia Detection in South Korea: A Targeted Screening Approach Integrating National Program and Genetic Cascade Screening.加强韩国家族性高胆固醇血症的检测：一种整合国家项目和基因级联筛查的靶向筛查方法。
Korean Circ J. 2024 Nov;54(11):726-738. doi: 10.4070/kcj.2024.0107. Epub 2024 Jul 1.
2
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia.国际动脉粥样硬化学会家族性高胆固醇血症管理最佳实践实施指南。
Nat Rev Cardiol. 2023 Dec;20(12):845-869. doi: 10.1038/s41569-023-00892-0. Epub 2023 Jun 15.
3
2022 Consensus Statement on the Management of Familial Hypercholesterolemia in Korea.《2022年韩国家族性高胆固醇血症管理共识声明》
J Lipid Atheroscler. 2022 Sep;11(3):213-228. doi: 10.12997/jla.2022.11.3.213. Epub 2022 Jul 7.
4
Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.全球家族性高胆固醇血症患病率的Meta 分析：1100 万例患者研究
J Am Coll Cardiol. 2020 May 26;75(20):2553-2566. doi: 10.1016/j.jacc.2020.03.057.
5
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).超过 60 个国家家族性高胆固醇血症治疗现状概述 - EAS 家族性高胆固醇血症研究协作组（FHSC）。
Atherosclerosis. 2018 Oct;277:234-255. doi: 10.1016/j.atherosclerosis.2018.08.051.
6
Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.家族性高胆固醇血症的临床基因检测：美国心脏病学会科学专家组。
J Am Coll Cardiol. 2018 Aug 7;72(6):662-680. doi: 10.1016/j.jacc.2018.05.044.
7
Familial hypercholesterolaemia.家族性高胆固醇血症。
Nat Rev Dis Primers. 2017 Dec 7;3:17093. doi: 10.1038/nrdp.2017.93.
8
Child-Parent Familial Hypercholesterolemia Screening in Primary Care.儿童-父母家族性高胆固醇血症的初级保健筛查。
N Engl J Med. 2016 Oct 27;375(17):1628-1637. doi: 10.1056/NEJMoa1602777.
9
Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.导致家族性高胆固醇血症的突变：对哥本哈根普通人群研究中的 98098 个人进行筛查，估计患病率为 1/217。
Eur Heart J. 2016 May 1;37(17):1384-94. doi: 10.1093/eurheartj/ehw028. Epub 2016 Feb 22.
Zotero 插件